인쇄하기
취소

Japanese encephalitis vaccine soon to launch in market.

Published: 2002-03-21 06:56:00
Updated: 2002-03-21 06:56:00
CDjavax, a Japanese encephalitis vaccine has been finally approved for the commercial release since it's conditional registration 5 years ago.

According to Hanyang Security Co., the registration condition was finally lifted on Mar. 16 with supplemental research data including the joint clinical studies with Yonsei Univ. and Texas State Univ. and 17 additional data on safety and efficacy.
...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.